Grupo Brasileiro de Estudos do Câncer de Mama

GBECAM is a leading Brazilian non-profit cooperative research group dedicated to advancing the treatment and understanding of breast cancer through clinical and translational research. Founded in 2005, the organization coordinates a vast network of oncology centers across Brazil to execute high-quality multicenter clinical trials. GBECAM collaborates extensively with international research networks, such as the Breast International Group (BIG), and global pharmaceutical companies to bring innovative therapies to the Latin American population. The group's activities include investigator-initiated trials, industry-sponsored studies, and the development of national clinical guidelines. By fostering scientific excellence and professional education, GBECAM plays a pivotal role in improving clinical outcomes for breast cancer patients in the region.